Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For MKTX
Valuation Weak
28%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 8.42 2.50 2.31
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 29.08 -3.08 -4.34
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.93 34.93 34.27
Cash -14.48 11.49 13.44
Capex -13.18 -0.40 -0.35
Free Cash Flow -84.76 -0.53 3.45
Revenue 7.55 5.61 5.21
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 2.60 0.81 0.79
Operating Margin 11.85 0.44 0.39
ROA 9.06 0.04 0.03
ROE 2.29 0.06 0.05
ROIC 7.12 0.05 0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of MKTX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of MKTX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of MKTX is permitted for members.